JPS56500569A - - Google Patents

Info

Publication number
JPS56500569A
JPS56500569A JP50092780A JP50092780A JPS56500569A JP S56500569 A JPS56500569 A JP S56500569A JP 50092780 A JP50092780 A JP 50092780A JP 50092780 A JP50092780 A JP 50092780A JP S56500569 A JPS56500569 A JP S56500569A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50092780A
Other languages
Japanese (ja)
Other versions
JPH0424360B2 (US06650917-20031118-M00005.png
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS56500569A publication Critical patent/JPS56500569A/ja
Publication of JPH0424360B2 publication Critical patent/JPH0424360B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP55500927A 1979-05-04 1980-05-05 Expired JPH0424360B2 (US06650917-20031118-M00005.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7911272A FR2472390A1 (fr) 1979-05-04 1979-05-04 Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus

Publications (2)

Publication Number Publication Date
JPS56500569A true JPS56500569A (US06650917-20031118-M00005.png) 1981-04-30
JPH0424360B2 JPH0424360B2 (US06650917-20031118-M00005.png) 1992-04-24

Family

ID=9225039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55500927A Expired JPH0424360B2 (US06650917-20031118-M00005.png) 1979-05-04 1980-05-05

Country Status (18)

Country Link
US (1) US4465623A (US06650917-20031118-M00005.png)
JP (1) JPH0424360B2 (US06650917-20031118-M00005.png)
AR (1) AR227021A1 (US06650917-20031118-M00005.png)
AT (1) ATA903980A (US06650917-20031118-M00005.png)
BE (1) BE883096A (US06650917-20031118-M00005.png)
CA (1) CA1157375A (US06650917-20031118-M00005.png)
CH (1) CH654329A5 (US06650917-20031118-M00005.png)
DE (1) DE3043409C3 (US06650917-20031118-M00005.png)
DK (1) DK157169C (US06650917-20031118-M00005.png)
ES (1) ES8100763A1 (US06650917-20031118-M00005.png)
FR (1) FR2472390A1 (US06650917-20031118-M00005.png)
GB (1) GB2061287B (US06650917-20031118-M00005.png)
IT (1) IT1131109B (US06650917-20031118-M00005.png)
MX (1) MX5960E (US06650917-20031118-M00005.png)
NL (1) NL8020152A (US06650917-20031118-M00005.png)
NO (1) NO155477C (US06650917-20031118-M00005.png)
SE (1) SE452250C (US06650917-20031118-M00005.png)
WO (1) WO1980002426A1 (US06650917-20031118-M00005.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0219400A (ja) * 1988-07-07 1990-01-23 Green Cross Corp:The トロンビンまたはプロトロンビンの製造方法

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663164A (en) * 1980-01-28 1987-05-05 Baxter Travenol Laboratories, Inc. Aqueous compositions for treating blood clotting factor inhibitors
WO1981002105A1 (en) * 1980-01-28 1981-08-06 Baxter Travenol Lab Therapeutic compositions & methods for manufacture and use
AT379310B (de) * 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
DE3727610A1 (de) * 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US6541275B1 (en) * 1988-02-03 2003-04-01 Dade Behring Inc. Immunoassay for F1.2 prothrombin fragment
WO1994022471A1 (en) * 1993-04-05 1994-10-13 The Green Cross Corporation Liquid antithrombin iii preparation and method of stabilizing the same
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US20080306610A1 (en) * 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
US8435305B2 (en) 2010-08-31 2013-05-07 Zimmer, Inc. Osteochondral graft delivery device and uses thereof
USD850006S1 (en) 2017-11-27 2019-05-28 Mary Kay Inc. Cosmetic compact
USD863685S1 (en) 2017-11-27 2019-10-15 Mary Kay Inc. Cosmetic compact
USD843660S1 (en) 2017-11-27 2019-03-19 Mary Kay Inc. Cosmetic compact

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
JPS4986515A (US06650917-20031118-M00005.png) * 1972-12-20 1974-08-19
JPS5426322A (en) * 1977-07-25 1979-02-27 Monsanto Co Separating of nineth factor preparation from serum

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
JPS4986515A (US06650917-20031118-M00005.png) * 1972-12-20 1974-08-19
JPS5426322A (en) * 1977-07-25 1979-02-27 Monsanto Co Separating of nineth factor preparation from serum

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0219400A (ja) * 1988-07-07 1990-01-23 Green Cross Corp:The トロンビンまたはプロトロンビンの製造方法

Also Published As

Publication number Publication date
IT1131109B (it) 1986-06-18
ATA903980A (de) 1982-05-15
DK157169C (da) 1990-04-23
DE3043409C2 (US06650917-20031118-M00005.png) 1993-12-23
SE452250B (sv) 1987-11-23
NL8020152A (nl) 1981-02-27
NO155477B (no) 1986-12-29
DE3043409C3 (de) 1993-12-23
ES491042A0 (es) 1980-12-01
DK157169B (da) 1989-11-20
IT8021723A0 (it) 1980-05-02
GB2061287B (en) 1983-09-14
SE8009157L (sv) 1980-12-29
ES8100763A1 (es) 1980-12-01
NO810009L (no) 1981-01-02
AR227021A1 (es) 1982-09-15
BE883096A (fr) 1980-11-03
FR2472390A1 (fr) 1981-07-03
GB2061287A (en) 1981-05-13
WO1980002426A1 (fr) 1980-11-13
DE3043409T1 (de) 1982-02-18
FR2472390B1 (US06650917-20031118-M00005.png) 1983-07-08
JPH0424360B2 (US06650917-20031118-M00005.png) 1992-04-24
DK1281A (da) 1981-01-02
CH654329A5 (fr) 1986-02-14
CA1157375A (fr) 1983-11-22
US4465623A (en) 1984-08-14
NO155477C (no) 1987-04-08
MX5960E (es) 1984-09-06
SE452250C (sv) 1998-04-06

Similar Documents

Publication Publication Date Title
DE3017500C2 (US06650917-20031118-M00005.png)
BR8002583A (US06650917-20031118-M00005.png)
FR2448764B1 (US06650917-20031118-M00005.png)
BR8006808A (US06650917-20031118-M00005.png)
JPS56500569A (US06650917-20031118-M00005.png)
DE3002280C2 (US06650917-20031118-M00005.png)
DE2915095C2 (US06650917-20031118-M00005.png)
FR2447637B1 (US06650917-20031118-M00005.png)
FR2445916B1 (US06650917-20031118-M00005.png)
DE2948054C3 (US06650917-20031118-M00005.png)
FR2447325B1 (US06650917-20031118-M00005.png)
FR2447464B1 (US06650917-20031118-M00005.png)
FR2447718B1 (US06650917-20031118-M00005.png)
FR2448315B1 (US06650917-20031118-M00005.png)
FR2448498B3 (US06650917-20031118-M00005.png)
AT364253B (US06650917-20031118-M00005.png)
FR2448041B1 (US06650917-20031118-M00005.png)
AU79557S (US06650917-20031118-M00005.png)
AU79950S (US06650917-20031118-M00005.png)
AU80228S (US06650917-20031118-M00005.png)
AU78385S (US06650917-20031118-M00005.png)
AU78386S (US06650917-20031118-M00005.png)
AU78389S (US06650917-20031118-M00005.png)
AU78271S (US06650917-20031118-M00005.png)
AU78390S (US06650917-20031118-M00005.png)